-
1
-
-
79959487586
-
Temporal trends in the prevalence of diabetic kidney disease in the United States
-
PMID: 21693741
-
de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011; 305: 2532-2539. doi: 10.1001/jama.2011.861 PMID: 21693741
-
(2011)
JAMA
, vol.305
, pp. 2532-2539
-
-
De Boer, I.H.1
Rue, T.C.2
Hall, Y.N.3
Heagerty, P.J.4
Weiss, N.S.5
Himmelfarb, J.6
-
2
-
-
84863672397
-
A study of the natural history of diabetic kidney disease (DKD)
-
PMID: 22058177
-
Altemtam N, Russell J, El Nahas M. A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transplant. 2012; 27: 1847-1854. doi: 10.1093/ndt/gfr561 PMID: 22058177
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 1847-1854
-
-
Altemtam, N.1
Russell, J.2
El Nahas, M.3
-
3
-
-
73749083481
-
Global estimates of the prevalence of diabetes for 2010 and 2030
-
PMID: 19896746
-
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 4-14. doi: 10.1016/j.diabres.2009.10.007 PMID: 19896746
-
(2010)
Diabetes Res Clin Pract
, vol.87
, pp. 4-14
-
-
Shaw, J.E.1
Sicree, R.A.2
Zimmet, P.Z.3
-
4
-
-
77950263954
-
Prevalence of diabetes among men and women in China
-
PMID: 20335585
-
Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362: 1090-1101. doi: 10.1056/NEJMoa0908292 PMID: 20335585
-
(2010)
N Engl J Med
, vol.362
, pp. 1090-1101
-
-
Yang, W.1
Lu, J.2
Weng, J.3
Jia, W.4
Ji, L.5
Xiao, J.6
-
5
-
-
84883416199
-
Prevalence and control of diabetes in Chinese adults
-
PMID: 24002281
-
Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013; 310: 948-959. doi: 10.1001/jama.2013.168118 PMID: 24002281
-
(2013)
JAMA
, vol.310
, pp. 948-959
-
-
Xu, Y.1
Wang, L.2
He, J.3
Bi, Y.4
Li, M.5
Wang, T.6
-
6
-
-
33646771273
-
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective
-
PMID: 16612330
-
Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG, investigators D. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006; 69: 2057-2063. PMID: 16612330
-
(2006)
Kidney Int
, vol.69
, pp. 2057-2063
-
-
Parving, H.H.1
Lewis, J.B.2
Ravid, M.3
Remuzzi, G.4
Hunsicker, L.G.5
-
7
-
-
84871995815
-
Standards of medical care in diabetes - 2013
-
PMID: 23264422
-
American Diabetes A. Standards of medical care in diabetes - 2013. Diabetes Care. 2013; 36 Suppl 1: S11-66. doi: 10.2337/dc13-S011 PMID: 23264422
-
(2013)
Diabetes Care
, vol.36
, pp. S11-S66
-
-
American Diabetes A1
-
8
-
-
7444221237
-
Preventing microalbuminuria in type 2 diabetes
-
PMID: 15516697
-
Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004; 351: 1941-1951. PMID: 15516697
-
(2004)
N Engl J Med
, vol.351
, pp. 1941-1951
-
-
Ruggenenti, P.1
Fassi, A.2
Ilieva, A.P.3
Bruno, S.4
Iliev, I.P.5
Brusegan, V.6
-
9
-
-
79952373965
-
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
-
PMID: 21388309
-
Haller H, Ito S, Izzo JL Jr., Januszewicz A, Katayama S, Menne J, et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011; 364: 907-917. doi: 10.1056/NEJMoa1007994 PMID: 21388309
-
(2011)
N Engl J Med
, vol.364
, pp. 907-917
-
-
Haller, H.1
Ito, S.2
Izzo, J.L.3
Januszewicz, A.4
Katayama, S.5
Menne, J.6
-
10
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
PMID: 11565518
-
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345: 861-869. PMID: 11565518
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
Keane, W.F.4
Mitch, W.E.5
Parving, H.H.6
-
11
-
-
77949877308
-
Avosentan for overt diabetic nephropathy
-
PMID: 20167702
-
Mann JF, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, et al. Avosentan for overt diabetic nephropathy. J Am Soc Nephrol. 2010; 21: 527-535. doi: 10.1681/ASN.2009060593 PMID: 20167702
-
(2010)
J Am Soc Nephrol
, vol.21
, pp. 527-535
-
-
Mann, J.F.1
Green, D.2
Jamerson, K.3
Ruilope, L.M.4
Kuranoff, S.J.5
Littke, T.6
-
12
-
-
77951645401
-
Effect of B-vitamin therapy on progression of diabetic nephropathy: A randomized controlled trial
-
PMID: 20424250
-
House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010; 303: 1603-1609. doi: 10.1001/jama.2010.490 PMID: 20424250
-
(2010)
JAMA
, vol.303
, pp. 1603-1609
-
-
House, A.A.1
Eliasziw, M.2
Cattran, D.C.3
Churchill, D.N.4
Oliver, M.J.5
Fine, A.6
-
13
-
-
84856211594
-
Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: A multicenter double-blinded randomized controlled trial
-
PMID: 22178174
-
Wang YJ, He LQ, Sun W, Lu Y, Wang XQ, Zhang PQ, et al. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial. J Ethnopharmacol. 2012; 139: 757-764. doi: 10.1016/j.jep.2011.12.009 PMID: 22178174
-
(2012)
J Ethnopharmacol
, vol.139
, pp. 757-764
-
-
Wang, Y.J.1
He, L.Q.2
Sun, W.3
Lu, Y.4
Wang, X.Q.5
Zhang, P.Q.6
-
14
-
-
84888378827
-
Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: A multicenter randomized controlled clinical trial
-
PMID: 23810688
-
Chen Y, Deng Y, Ni Z, Chen N, Chen X, Shi W, et al. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial. Am J Kidney Dis. 2013; 62: 1068-1076. doi: 10.1053/j.ajkd.2013.05.005 PMID: 23810688
-
(2013)
Am J Kidney Dis
, vol.62
, pp. 1068-1076
-
-
Chen, Y.1
Deng, Y.2
Ni, Z.3
Chen, N.4
Chen, X.5
Shi, W.6
-
15
-
-
84866465319
-
Rheum officinale (a traditional Chinese medicine) for chronic kidney disease
-
Wang H, Song H, Yue J, Li J, Hou YB, Deng JL. Rheum officinale (a traditional Chinese medicine) for chronic kidney disease. Cochrane Database Syst Rev. 2012; 7: CD008000.
-
(2012)
Cochrane Database Syst Rev
, vol.7
-
-
Wang, H.1
Song, H.2
Yue, J.3
Li, J.4
Hou, Y.B.5
Deng, J.L.6
-
16
-
-
84861015626
-
Astragalus injection for hypertensive renal damage: A systematic review
-
PMID: 22577466
-
Sun T, Xu H, Xu F. Astragalus injection for hypertensive renal damage: a systematic review. Evid Based Complement Alternat Med. 2012; 2012: 929025. doi: 10.1155/2012/929025 PMID: 22577466
-
(2012)
Evid Based Complement Alternat Med
, vol.2012
, pp. 929025
-
-
Sun, T.1
Xu, H.2
Xu, F.3
-
17
-
-
84884240776
-
The effect of chinese herbal medicine on albuminuria levels in patients with diabetic nephropathy: A systematic review and meta-analysis
-
PMID: 24062795
-
Xiao Y, Liu Y, Yu K, Zhou L, Bi J, Cheng J, et al. The effect of chinese herbal medicine on albuminuria levels in patients with diabetic nephropathy: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2013; 2013: 937549. doi: 10.1155/2013/937549 PMID: 24062795
-
(2013)
Evid Based Complement Alternat Med
, vol.2013
, pp. 937549
-
-
Xiao, Y.1
Liu, Y.2
Yu, K.3
Zhou, L.4
Bi, J.5
Cheng, J.6
-
18
-
-
84929176136
-
Clinical observation on treatment of diabetic nephropathy by Tangshen capsule
-
Chinese.
-
Feng J, Ni Q. Clinical observation on treatment of diabetic nephropathy by Tangshen capsule. Chinese Journal of Integrative Medicine. 2000; 20: 212-214. Chinese.
-
(2000)
Chinese Journal of Integrative Medicine
, vol.20
, pp. 212-214
-
-
Feng, J.1
Ni, Q.2
-
19
-
-
79952179765
-
Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula)
-
PMID: 21274280
-
Zhang H, Li P, Burczynski FJ, Gong Y, Choy P, Sha H, et al. Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula). Evid Based Complement Alternat Med. 2011; 2011: 613737. doi: 10.1155/2011/613737 PMID: 21274280
-
(2011)
Evid Based Complement Alternat Med
, vol.2011
, pp. 613737
-
-
Zhang, H.1
Li, P.2
Burczynski, F.J.3
Gong, Y.4
Choy, P.5
Sha, H.6
-
20
-
-
79960621314
-
Renal protective effect of TangshenFormula in rats with diabetic nephropathy
-
Chinese.
-
Zhang H, Li P, Zhao J, Zhao S, Luo Y, Sha H, et al. Renal protective effect of TangshenFormula in rats with diabetic nephropathy. Journal of Beijing University of Traditional Chinese Medicine. 2009; 32: 244-248. Chinese.
-
(2009)
Journal of Beijing University of Traditional Chinese Medicine
, vol.32
, pp. 244-248
-
-
Zhang, H.1
Li, P.2
Zhao, J.3
Zhao, S.4
Luo, Y.5
Sha, H.6
-
22
-
-
32144448938
-
Standards of medical care in diabetes - 2006
-
PMID: 16373931
-
American Diabetes Association. Standards of medical care in diabetes - 2006. Diabetes Care. 2006; 29 Suppl 1: S4-42. PMID: 16373931
-
(2006)
Diabetes Care
, vol.29
, pp. S4-S42
-
-
American Diabetes Association1
-
23
-
-
33845760213
-
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
-
PMID: 17276798
-
KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007; 49: S12-154. PMID: 17276798
-
(2007)
Am J Kidney Dis
, vol.49
, pp. S12-S154
-
-
KDOQI1
-
24
-
-
33645548976
-
-
Beijing: Chemical Industry Press Chinese
-
Chinese Pharmacopoeia Commission. Chinese pharmacopoeia. Beijing: Chemical Industry Press.2005. Chinese.
-
(2005)
Chinese Pharmacopoeia
-
-
-
25
-
-
0031775905
-
Development of the World Health Organization WHOQOL-BREF quality of life assessment
-
PMID: 9626712
-
The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998; 28: 551-558. PMID: 9626712
-
(1998)
Psychol Med
, vol.28
, pp. 551-558
-
-
-
27
-
-
80052369012
-
Effect of Tangshen Formula on expression of TGF-β1 and MMP-9 of renal tissue in STZ- induced diabetic nephropathy rats
-
Chinese
-
Zhang H, Li P, Zhao JB, Zhao SJ, Yan MH, Luo YH, et al. Effect of Tangshen Formula on expression of TGF-β1 and MMP-9 of renal tissue in STZ- induced diabetic nephropathy rats. Chinese Journal of Integrated Traditional and Western Nephrology. 2009; 10: 290-294. Chinese.
-
(2009)
Chinese Journal of Integrated Traditional and Western Nephrology
, vol.10
, pp. 290-294
-
-
Zhang, H.1
Li, P.2
Zhao, J.B.3
Zhao, S.J.4
Yan, M.H.5
Luo, Y.H.6
-
28
-
-
78651402015
-
Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy
-
PMID: 20951192
-
Li M, Wang W, Xue J, Gu Y, Lin S. Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy. J Ethnopharmacol. 2011; 133: 412-419. doi: 10.1016/j.jep.2010.10.012 PMID: 20951192
-
(2011)
J Ethnopharmacol
, vol.133
, pp. 412-419
-
-
Li, M.1
Wang, W.2
Xue, J.3
Gu, Y.4
Lin, S.5
-
29
-
-
70350342864
-
Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models
-
PMID: 19735713
-
Zhang J, Xie X, Li C, Fu P. Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models. J Ethnopharmacol. 2009; 126: 189-196. doi: 10.1016/j.jep.2009.08.046 PMID: 19735713
-
(2009)
J Ethnopharmacol
, vol.126
, pp. 189-196
-
-
Zhang, J.1
Xie, X.2
Li, C.3
Fu, P.4
-
30
-
-
84900828237
-
Effects of astragalus injection on the TGFbeta/Smad pathway in the kidney in type 2 diabetic mice
-
PMID: 24885228
-
Nie Y, Li S, Yi Y, Su W, Chai X, Jia D, et al. Effects of astragalus injection on the TGFbeta/Smad pathway in the kidney in type 2 diabetic mice. BMC Complement Altern Med. 2014; 14: 148. doi: 10.1186/1472-6882-14-148 PMID: 24885228
-
(2014)
BMC Complement Altern Med
, vol.14
, pp. 148
-
-
Nie, Y.1
Li, S.2
Yi, Y.3
Su, W.4
Chai, X.5
Jia, D.6
-
31
-
-
84871265235
-
Euonymus alatus in the treatment of diabetic nephropathy in rats
-
PMID: 23227790
-
Chang B, Jin C, Zhang W, Kong L, Yang JH, Lian FM, et al. Euonymus alatus in the treatment of diabetic nephropathy in rats. Am J Chin Med. 2012; 40: 1177-1187. doi: 10.1142/S0192415X12500875 PMID: 23227790
-
(2012)
Am J Chin Med
, vol.40
, pp. 1177-1187
-
-
Chang, B.1
Jin, C.2
Zhang, W.3
Kong, L.4
Yang, J.H.5
Lian, F.M.6
-
32
-
-
84866732340
-
Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products
-
PMID: 22327862
-
Baek GH, Jang YS, Jeong SI, Cha J, Joo M, Shin SW, et al. Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products. Inflammation. 2012; 35: 1232-1241. doi: 10.1007/s10753-012-9433-x PMID: 22327862
-
(2012)
Inflammation
, vol.35
, pp. 1232-1241
-
-
Baek, G.H.1
Jang, Y.S.2
Jeong, S.I.3
Cha, J.4
Joo, M.5
Shin, S.W.6
-
33
-
-
84880803069
-
Effect of catalpol on diabetic nephropathy in rats
-
PMID: 23746755
-
Dong Z, Chen CX. Effect of catalpol on diabetic nephropathy in rats. Phytomedicine. 2013; 20: 1023-1029. doi: 10.1016/j.phymed.2013.04.007 PMID: 23746755
-
(2013)
Phytomedicine
, vol.20
, pp. 1023-1029
-
-
Dong, Z.1
Chen, C.X.2
-
34
-
-
82055194290
-
Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats
-
PMID: 22056647
-
Srinivasan S, Pari L. Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Chem Biol Interact. 2012; 195: 43-51. doi: 10.1016/j.cbi.2011.10.003 PMID: 22056647
-
(2012)
Chem Biol Interact
, vol.195
, pp. 43-51
-
-
Srinivasan, S.1
Pari, L.2
-
35
-
-
16644371234
-
Effects of iridoid total glycoside from Cornus officinalis on prevention of glomerular overexpression of transforming growth factor beta 1 and matrixes in an experimental diabetes model
-
PMID: 15256732
-
Xu HQ, Hao HP. Effects of iridoid total glycoside from Cornus officinalis on prevention of glomerular overexpression of transforming growth factor beta 1 and matrixes in an experimental diabetes model. Biol Pharm Bull. 2004; 27: 1014-1018. PMID: 15256732
-
(2004)
Biol Pharm Bull
, vol.27
, pp. 1014-1018
-
-
Xu, H.Q.1
Hao, H.P.2
-
36
-
-
74349098549
-
Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy
-
PMID: 19639539
-
Gao Q, Qin WS, Jia ZH, Zheng JM, Zeng CH, Li LS, et al. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Med. 2010; 76: 27-33. doi: 10.1055/s-0029-1185948 PMID: 19639539
-
(2010)
Planta Med
, vol.76
, pp. 27-33
-
-
Gao, Q.1
Qin, W.S.2
Jia, Z.H.3
Zheng, J.M.4
Zeng, C.H.5
Li, L.S.6
-
37
-
-
84897975038
-
Anti-diabetic potential of Panax notoginseng saponins (PNS): A review
-
PMID: 23846979
-
Uzayisenga R, Ayeka PA, Wang Y. Anti-diabetic potential of Panax notoginseng saponins (PNS): a review. Phytother Res. 2014; 28: 510-516. doi: 10.1002/ptr.5026 PMID: 23846979
-
(2014)
Phytother Res
, vol.28
, pp. 510-516
-
-
Uzayisenga, R.1
Ayeka, P.A.2
Wang, Y.3
-
38
-
-
67651180928
-
Effect on proliferation of glomerular mesangial cell by the dose compatible proportion between Radix Astrsgali and Radix Notoginseng in Tongmai Oral Liquid
-
Chinese
-
Liu M, Huang Z, Wu Q, P. W. Effect on proliferation of glomerular mesangial cell by the dose compatible proportion between Radix Astrsgali and Radix Notoginseng in Tongmai Oral Liquid. Journal of Xi'an Jiaotong University (Medical Sciences). 2009; 30: 377-379. Chinese.
-
(2009)
Journal of Xi'an Jiaotong University (Medical Sciences)
, vol.30
, pp. 377-379
-
-
Liu, M.1
Huang, Z.2
Wu, Q.3
W, P.4
-
39
-
-
84863393388
-
Pyridorin in type 2 diabetic nephropathy
-
PMID: 22034637
-
Lewis EJ, Greene T, Spitalewiz S, Blumenthal S, Berl T, Hunsicker LG, et al. Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol. 2012; 23: 131-136. doi: 10.1681/ASN.2011030272 PMID: 22034637
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 131-136
-
-
Lewis, E.J.1
Greene, T.2
Spitalewiz, S.3
Blumenthal, S.4
Berl, T.5
Hunsicker, L.G.6
-
40
-
-
77958158176
-
A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy
-
PMID: 20413516
-
Alkhalaf A, Klooster A, van Oeveren W, Achenbach U, Kleefstra N, Slingerland RJ, et al. A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy. Diabetes Care. 2010; 33: 1598-1601. doi: 10.2337/dc09-2241 PMID: 20413516
-
(2010)
Diabetes Care
, vol.33
, pp. 1598-1601
-
-
Alkhalaf, A.1
Klooster, A.2
Van Oeveren, W.3
Achenbach, U.4
Kleefstra, N.5
Slingerland, R.J.6
-
41
-
-
84863393468
-
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy
-
PMID: 22034636
-
Packham DK, Wolfe R, Reutens AT, Berl T, Heerspink HL, Rohde R, et al. Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. J Am Soc Nephrol. 2012; 23: 123-130. doi: 10.1681/ASN.2011040378 PMID: 22034636
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 123-130
-
-
Packham, D.K.1
Wolfe, R.2
Reutens, A.T.3
Berl, T.4
Heerspink, H.L.5
Rohde, R.6
-
42
-
-
84865642129
-
Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)
-
PMID: 22333485
-
Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, et al. Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE). J Renin Angiotensin Aldosterone Syst. 2012; 13: 387-393. doi: 10.1177/1470320311434818 PMID: 22333485
-
(2012)
J Renin Angiotensin Aldosterone Syst
, vol.13
, pp. 387-393
-
-
Parving, H.H.1
Brenner, B.M.2
McMurray, J.J.3
De Zeeuw, D.4
Haffner, S.M.5
Solomon, S.D.6
-
43
-
-
77951621387
-
Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: A meta-analysis
-
PMID: 20110146
-
Sarafidis PA, Stafylas PC, Georgianos PI, Saratzis AN, Lasaridis AN. Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis. Am J Kidney Dis. 2010; 55: 835-847. doi: 10.1053/j.ajkd.2009.11.013 PMID: 20110146
-
(2010)
Am J Kidney Dis
, vol.55
, pp. 835-847
-
-
Sarafidis, P.A.1
Stafylas, P.C.2
Georgianos, P.I.3
Saratzis, A.N.4
Lasaridis, A.N.5
-
44
-
-
84869487794
-
Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy
-
PMID: 22723267
-
Pistrosch F, Passauer J, Herbrig K, Schwanebeck U, Gross P, Bornstein SR. Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy. Horm Metab Res. 2012; 44: 914-918. doi: 10.1055/s-0032-1314836 PMID: 22723267
-
(2012)
Horm Metab Res
, vol.44
, pp. 914-918
-
-
Pistrosch, F.1
Passauer, J.2
Herbrig, K.3
Schwanebeck, U.4
Gross, P.5
Bornstein, S.R.6
-
45
-
-
77950507168
-
Heart failure events with rosiglitazone in type 2 diabetes: Data from the RECORD clinical trial
-
PMID: 20118174
-
Komajda M, McMurray JJ, Beck-Nielsen H, Gomis R, Hanefeld M, Pocock SJ, et al. Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J. 2010; 31: 824-831. doi: 10.1093/eurheartj/ehp604 PMID: 20118174
-
(2010)
Eur Heart J
, vol.31
, pp. 824-831
-
-
Komajda, M.1
McMurray, J.J.2
Beck-Nielsen, H.3
Gomis, R.4
Hanefeld, M.5
Pocock, S.J.6
-
46
-
-
84865858873
-
Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: A meta-analysis
-
PMID: 22761478
-
Colmers IN, Bowker SL, Majumdar SR, Johnson JA. Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis. CMAJ. 2012; 184: E675-683. doi: 10.1503/cmaj.112102 PMID: 22761478
-
(2012)
CMAJ
, vol.184
, pp. E675-E683
-
-
Colmers, I.N.1
Bowker, S.L.2
Majumdar, S.R.3
Johnson, J.A.4
-
47
-
-
84866707482
-
Association between longer therapy with thiazolidinediones and risk of bladder cancer: A cohort study
-
PMID: 22878886
-
Mamtani R, Haynes K, Bilker WB, Vaughn DJ, Strom BL, Glanz K, et al. Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst. 2012; 104: 1411-1421. PMID: 22878886
-
(2012)
J Natl Cancer Inst
, vol.104
, pp. 1411-1421
-
-
Mamtani, R.1
Haynes, K.2
Bilker, W.B.3
Vaughn, D.J.4
Strom, B.L.5
Glanz, K.6
-
48
-
-
33745087214
-
Progression of kidney dysfunction in the community-dwelling elderly
-
PMID: 16531986
-
Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006; 69: 2155-2161. PMID: 16531986
-
(2006)
Kidney Int
, vol.69
, pp. 2155-2161
-
-
Hemmelgarn, B.R.1
Zhang, J.2
Manns, B.J.3
Tonelli, M.4
Larsen, E.5
Ghali, W.A.6
-
49
-
-
7444237666
-
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
-
PMID: 15516696
-
Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, et al. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med. 2004; 351: 1952-1961. PMID: 15516696
-
(2004)
N Engl J Med
, vol.351
, pp. 1952-1961
-
-
Barnett, A.H.1
Bain, S.C.2
Bouter, P.3
Karlberg, B.4
Madsbad, S.5
Jervell, J.6
-
50
-
-
78649929199
-
Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy
-
PMID: 20693353
-
Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Parving HH, et al. Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy. Diabetes Care. 2010; 33: 2304-2309. doi: 10.2337/dc10-0833 PMID: 20693353
-
(2010)
Diabetes Care
, vol.33
, pp. 2304-2309
-
-
Persson, F.1
Lewis, J.B.2
Lewis, E.J.3
Rossing, P.4
Hollenberg, N.K.5
Parving, H.H.6
|